Adaptive Biotechnologies makes immune system based cancer tests and sells immune data to clinicians and drug developers. It last closed at $28.49 on Nov 17, up 2.22% on the day. ADPT reports earnings on Thu, Feb 4, 2027. The average 12-month price target from 5 analysts is $32.40 (+13.7% from the last close), with a high of $35.00 and a low of $27.00. Analyst consensus is Strong Buy, based on the latest ratings from 5 firms (4 buy, 1 hold, 0 sell).
Each firm's latest rating on ADPT in the past 90 days
Average 12-month target
$32.40
▲ 13.7% upside
Based on 5 analysts who set a price target on ADPT in the past 90 days. The average target is $32.40, with a high of $35.00 and a low of $27.00, compared with the last close of $28.49.
Low $27.00Avg $32.40High $35.00
Blue marker: last close $28.49
Highest target$35.00
Average target$32.40
Lowest target$27.00
Latest rating changes
GuggenheimTarget raised
Nov 10Buy$32 → $34
TD CowenTarget raised
Oct 13Buy$28 → $32
Morgan StanleyTarget raised
Oct 13Hold$22 → $27
GuggenheimTarget raised
Oct 1Buy$25 → $32
Goldman SachsInitiated
Sep 29Buy$35
Date
Firm
Action
Rating
Price target
Nov 10
Guggenheim
Target raised
Buy
$32 → $34
Oct 13
TD Cowen
Target raised
Buy
$28 → $32
Oct 13
Morgan Stanley
Target raised
Hold
$22 → $27
Oct 1
Guggenheim
Target raised
Buy
$25 → $32
Sep 29
Goldman Sachs
Initiated
Buy
$35
Loading…
Technical Analysis
ADPT · as of the Nov 17 close · updated after every close
Uptrend
The stock is 4% above its 20 day and 5% above its 50 day average. It is 29% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 54). The nearest support is the Pivot at $28.43, and the nearest resistance the swing high (Oct 28) at $29.05.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityHigh, 6.0%/day
Key levels
$32.1352 week high+12.8%
$29.24Pivot R1+2.6%
$29.05Swing high (Oct 28)+2.0%
$28.49Last close
$28.43Pivot−0.2%
$27.68Pivot S1−2.8%
$27.4620 day average−3.6%
$27.0650 day average−5.0%
$26.73Swing low (Sep 22)−6.2%
$25.30100 day average−11.2%
$20.19200 day average−29.1%
$12.0052 week low−57.9%
Indicators
RSI (14)
54.43
Middle of its range
Neutral
MACD
0.70
Above its signal line
Bullish
Stochastic
50.0
Middle of its range
Neutral
ADX (14)
17.7
No clear trend
Williams %R
-49.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
46.0
Oversold below −100, overbought above 100
Neutral
Rate of change
+10.4%
Change over 10 sessions
Bullish
ATR (14)
$1.72
Typical daily range, 6.0% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Rising, nearing overbought
Short trendBullish
Long trendNot enough history
MomentumImproving
StretchNear overbought
VolatilityNormal, 9.8%/day
Key levels
$32.1352 week high+12.8%
$29.24Pivot R1+2.6%
$29.05Swing high (Oct 28)+2.0%
$28.49Last close
$28.43Pivot−0.2%
$27.68Pivot S1−2.8%
$27.4620 day average−3.6%
$27.0650 day average−5.0%
$26.73Swing low (Sep 22)−6.2%
$25.30100 day average−11.2%
$20.19200 day average−29.1%
$12.0052 week low−57.9%
Indicators
RSI (14)
63.94
Strong, overbought above 70
Neutral
MACD
2.53
Below its signal line
Bearish
Stochastic
63.6
Middle of its range
Neutral
ADX (14)
38.7
Trending up
Williams %R
-42.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
94.1
Oversold below −100, overbought above 100
Neutral
Rate of change
+17.7%
Change over 10 sessions
Bullish
ATR (14)
$2.79
Typical daily range, 9.8% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for ADPT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ADPT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow ADPT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How ADPT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ADPT is in one of them and how their past ADPT trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Adaptive Biotechnologies
Adaptive Biotechnologies is a life sciences company based in Seattle, Washington. It uses sequencing and data analysis of the immune system to develop medical tests and products. Its main product, clonoSEQ, measures residual disease in patients with blood cancers and is sold to clinicians. It also runs testing for biopharmaceutical companies developing new drugs and licenses its immune system data to drug developers.